Tag: CBT > Business Issues/ Benchmarks > Finance: Page 5

Finance

TerrAscend Offers $10 Million Share Repurchase Program

The company is authorized to repurchase up to 10 million shares but is not obligated to purchase any shares during the 12-month stock buyback program.

August 20, 2024

Finance

Curaleaf Reports $342 Million in Q2 Revenue

The global cannabis company now operates in 15 countries.

August 8, 2024

Finance

The Cannabist Co. Reports Second Quarter 2024 Financial Results

The company reported $125 million in revenue for the period.

August 8, 2024

Finance

Cresco Labs Determines IRS Section 280E Not Applicable to its Business

The company reported an improvement of more than 800 basis points year-over-year in its adjusted EBITDA margin for the second quarter of 2024.

August 8, 2024

Finance

Verano Reports $222 Million in Revenue for Q2

The company’s second quarter 2024 financial performance featured the authorization of a share repurchase program.

August 7, 2024

Finance

Trulieve Reports $303 Million in Revenue in Q2 2024 Financial Results

The company’s revenue exceeded quarterly guidance in the second quarter as it looks ahead to Ohio’s adult-use sales launch at three retail locations.

August 6, 2024

Finance

Green Thumb CEO Urges DEA to ‘Do Their Job’ for Cannabis Rescheduling

Ben Kovler’s remarks came with the company’s second quarter financial results, which featured $280 million in revenue, an 11% year-over-year increase.

August 5, 2024

Finance

SNDL Initiates Overhead Restructuring, Operational Adjustments Impacting 106 Employees

The project is expected to deliver more than $20 million in annualized cost savings driven primarily by the optimization of corporate overhead spending.

July 16, 2024

Finance

Ascend Wellness Holdings Signs Definitive Agreements to Issue $235 Million of Senior Secured Notes

The company secured funding with a 12.75% coupon and a five-year term; the net proceeds will refinance an existing term loan.

July 15, 2024

Finance

Canopy Growth Establishes US$250 Million At-The-Market Program To Further Enhance the Company's Financial Position And Facilitate Growth

Global cannabis company Canopy Growth Corporation has established an at-the-market equity program (the 'ATM Program') that allows the company to issue and sell up to US$250 million (or its Canadian dollar equivalent) of common shares of the company from treasury from time to time in concurrent public offerings in the United States and Canada.

June 6, 2024

Finance

Acreage Announces Corporate Transactions Associated With Canopy USA Deal

The acquisition of Acreage by Canopy USA is expected to close in the first half of 2025.

June 4, 2024

Finance

Cresco Labs Reports $184M in Revenue in Q1 2024 Financial Results

'This is just the start,' says CEO Charles Bachtell, noting significant opportunities in new and potential adult-use markets such as Ohio, Florida and Pennsylvania.

May 15, 2024